Quick Takeaways
- Backstrom Jay T. has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $16,062,247.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Backstrom Jay T. and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | CHIEF EXECUTIVE OFFICER, Director | $16,062,247 | 10 Mar 2025 | ||
| XLRN | ACCELERON PHARMA INC | EVP, Research and Development | 19 Nov 2021 | |||
| AGIO | AGIOS PHARMACEUTICALS, INC. | Director | 08 Jul 2025 | |||
| IRON | Disc Medicine, Inc. | Director | 29 Dec 2022 | |||
| LVTX | LAVA Therapeutics NV | Director | 13 Nov 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|